The epidemiology of peripheral arterial disease: Importance of identifying the population at risk

Vascular Medicine

Volumn 2, Issue 3, 1997, Pages 221-226

  Criqui, Michael H ^a   Denenberg, Julie O ^a   Langer, Robert D ^a   Fronek, Arnost ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY DISEASE; CEREBROVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HIGH RISK POPULATION; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030726995     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X9700200310     Document Type: Conference Paper

References (34)

1. Kannel WB, Skinner JJ Jr, Schwartz MJ, Shurtleff D. Intermittent claudication: incidence in the Framingham Study. Circulation 1970; 41: 875-83.
2. Ludbrook J, Clarke AM, McKenzie JK. Significance of absent ankle pulse. Br Med J 1962; i: 1724-26.
3. Reid DD, Brett GZ, Hamilton PJS et al. Cardiorespiratory disease and diabetes among middle-aged male civil servants: a study of screening and intervention. Lancet 1974; i: 469-73.
4. Hughson WG, Mann JI, Garrod A. Intermittent claudication: prevalence and risk factors. Br Med J 1978; i: 1379-81.
5. Reunanen A, Takkunen H, Aroma A. Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 1982; 211: 249-56.
6. Criqui MH, Fronek A, Barrett-Connor E et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510-15.
7. Fronek A, Johnson KH, Dilley RB, Bernstein EF. Non-invasive physiologic tests in the diagnosis and characterization of peripheral arterial occlusive disease. Am J Surg 1973; 126: 205-14.
8. Feigelson HS, Criqui MH, Fronek A et al Diagnosing peripheral arterial disease: the sensitivity, specificity, and predictive value of non-invasive tests in a defined population. Am J Epidemiol 1994, 140: 518-25.
9. Kiekara O, Riekkinen H, Soimakallio S, Lansimies E. Correlation of angiographically determined reduction of vascular lumen with lower-limb systolic pressures. Acta Chir Scand 1985; 151: 437-40.
10. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation 1995; 91: 1472-79.
11. Vogt MT, Cauley JA, Newman AB et al. Decreased ankle/arm blood pressure index and mortality in elderly women JAMA 1993; 270: 465-69.
12. Criqui MH, Langer RD, Fronek A et al. Large vessel and isolated small vessel disease. In: Fowkes FGR ed. Epidemiology of peripheral vascular disease. London: Springer-Verlag, 1991: 85-96
13. Criqui MH, Browner D, Fronek A et al. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease: an analysis of risk factors. Am J Epidemiol 1989, 129: 1110-19.
14. Reaven G. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
15. Austin MA, Breslow JL, Hennekens CH, Grundy SM. Lp(a). Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917-21.
16. Valentine JR, Grayburn PA, Vega GL, Grundy SM. Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men. Arch Intern Med 1994; 154: 801-806.
17. Malinow MR, Kang SS, Taylor LM et al. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989; 79: 1180-88.
18. Lowe GDO, Fowkes FGR, Dawes J et al. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study Circulation 1993; 87: 1915-20.
19. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results JAMA 1984; 251: 351-64.
20. Buchwald H, Varco RL, Matts JP et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia N Engl J Med 1990; 323: 946-55.
21. De Felice M, Gallo P, Masotti G. Current therapy of peripheral obstructive arterial disease. The non-surgical approach. Angiology 1990; 41: 1-11.
22. Goldhaber SZ, Manson JE, Stampfer MJ et al. Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study. Lancet 1992; 340: 143-45
23. Balsano F, Violi F, ADEP Group Effect of picotamide on the clinical progression of peripheral vascular disease. Circulation 1993; 87: 1563-69.
24. Dormandy J, Mahir M, Ascada G et al. Fate of the patient with chronic leg ischaemia. J Cardiovasc Surg 1989; 30: 50-57.
25. Peabody CN, Kannel WB, McNamara PM Intermittent claudication: surgical significance. Arch Surg 1974; 109: 693-97
26. Jelnes R, Gaardsting O, Hougaard-Jensen K et al. Fate in intermittent claudication: outcome and risk factors. Br Med J 1986; 293: 1137-40.
27. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors and mortality: the Whitehall Study. Circulation 1990; 82: 1925-31.
28. Criqui MH, Coughlin SS, Fronek A. Non-invasively diagnosed peripheral arterial disease as a predictor of mortality. Results from a prospective population-based study. Circulation 1985; 72: 768-73.
29. Criqui MH, Fronek A, Klauber MR et al. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from non-invasive testing in a defined population. Circulation 1985, 71: 516-21.
30. Criqui MH, Langer RD, Fronek A et al. Mortality over a period of 10 years in patients with peripheral arterial disease N Engl J Med 1992; 326: 381-86.
31. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991; 87: 119-28.
32. Criqui MH, Langer RD, Fvonek A, Feigelson HS. Coronary disease and stroke in patients with large vessel peripheral arterial disease Drugs 1991; 42 (suppl. 5): 16-21.
33. Expert Panel on Detection, Evaluation, and Treatment Of High Blood Cholesterol In Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. (Adult Treatment Panel II.) JAMA 1993; 269: 3015-23.
34. CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.